Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
32.09x6.1x0.76x8.33x25.19x25.92x0.06% 54.5B
15.65x2.98x-1.63x4.68x10.16x11.8x1.92% 41.73B
-17.03x1.06x2.62x3.77x-6.6x-5.35x-.--% 21.87B
-36.96x50.31x0.63x12.36x-36.11x-39.11x-.--% 21.47B
21.36x2.43x-0.96x4.28x14.19x15.8x-.--% 15.29B
16.78x4.75x1.23x4.84x11.33x12.48x-.--% 13.32B
38.49x9.55x0.43x14.82x43.53x38.78x0.17% 11.63B
-404.46x16.6x8.21x27.48x-3063.87x-300.79x-.--% 11.53B
-12.62x148.26x0.61x3280.51x-15.32x-12.46x-.--% 11.09B
-69.82x24.46x1.49x6.99x-65.97x-51.38x-.--% 11B
1091.71x7.53x-10.32x12.73x72.23x175.84x-.--% 10.51B
-23.22x23.85x-0x21.05x-27.02x-21.86x-.--% 10.33B
-21.32x8.24x18.42x766.24x-18.68x-18.59x-.--% 9.74B
-10.59x-43.88x9.12x79.71x-11.89x-11.58x-.--% 9.29B
-8.53x - -0.07x - - - - 7.59B
10.23x4.9x0.03x6.51x10.54x11.13x-.--% 7.18B
114.32x2.31x-2.01x4.59x22.78x49.72x0.13% 7.07B
25.38x4.15x-2.02x5.72x22.27x25.41x - 6.85B
-5.5x - -0.11x - -5.64x-5.18x-.--% 6.77B
Average 39.79x 16.09x 1.39x 250.86x -167.71x -5.52x 0.13% 15.2B
Weighted average by Cap. 29.61x 14.41x 1.02x 170.37x -120.64x -1.63x 0.31%
Bio Therapeutic Drugs
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!